Method of inducing memory B cell development and terminal differentiation
A method is disclosed herein for inducing differentiation of a B cell progenitor into a memory B cells and/or a plasma cell. The method includes contacting a population of cells including a mature B cell or a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Ettinger, Catherine Rachel Lipsky, Peter E Leonard, Warren J Spolski, Rosanne Morse, III, Herbert C |
description | A method is disclosed herein for inducing differentiation of a B cell progenitor into a memory B cells and/or a plasma cell. The method includes contacting a population of cells including a mature B cell or a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. In one embodiment, the B cell progenitor is an immature B cell. A method is also disclosed for enhancing an immune response. The method includes contacting a population of cells including a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. The memory B cells and/or the plasma cell are then introduced into the subject to enhance the immune response. A method is also disclosed for treating a subject with a condition comprising a specific deficiency of at least one of memory B cells and plasma cells. A method is disclosed for identifying an agent with a physiological effect on one or more of a memory B cell and a plasma cell differentiation. A method is also disclosed for identifying agents that inhibit an activity of IL-21. Methods are also disclosed for inducing apoptosis of a B cell and for decreasing the number of B cells. A method is also described for producing a B cell hybridoma. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07378276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07378276</sourcerecordid><originalsourceid>FETCH-uspatents_grants_073782763</originalsourceid><addsrcrecordid>eNqNikEKAjEMAHvxIOof8gFBXLCeFUUP3rxL2KZroE2WNiv4eyv4AE8DMzN31xvZUwNoBJYw9SwDZMpa3nCAnlKCQC9KOmYSA5QARiWzYAscI5WmGY1Vlm4WMVVa_bhwcD7dj5f1VEe0ttXHUPCLje_8fut33R_LB5zeNb0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Method of inducing memory B cell development and terminal differentiation</title><source>USPTO Issued Patents</source><creator>Ettinger, Catherine Rachel ; Lipsky, Peter E ; Leonard, Warren J ; Spolski, Rosanne ; Morse, III, Herbert C</creator><creatorcontrib>Ettinger, Catherine Rachel ; Lipsky, Peter E ; Leonard, Warren J ; Spolski, Rosanne ; Morse, III, Herbert C ; The United States of America as represented by the Department of Health and Human Services</creatorcontrib><description>A method is disclosed herein for inducing differentiation of a B cell progenitor into a memory B cells and/or a plasma cell. The method includes contacting a population of cells including a mature B cell or a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. In one embodiment, the B cell progenitor is an immature B cell. A method is also disclosed for enhancing an immune response. The method includes contacting a population of cells including a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. The memory B cells and/or the plasma cell are then introduced into the subject to enhance the immune response. A method is also disclosed for treating a subject with a condition comprising a specific deficiency of at least one of memory B cells and plasma cells. A method is disclosed for identifying an agent with a physiological effect on one or more of a memory B cell and a plasma cell differentiation. A method is also disclosed for identifying agents that inhibit an activity of IL-21. Methods are also disclosed for inducing apoptosis of a B cell and for decreasing the number of B cells. A method is also described for producing a B cell hybridoma.</description><language>eng</language><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7378276$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,777,799,882,64018</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7378276$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ettinger, Catherine Rachel</creatorcontrib><creatorcontrib>Lipsky, Peter E</creatorcontrib><creatorcontrib>Leonard, Warren J</creatorcontrib><creatorcontrib>Spolski, Rosanne</creatorcontrib><creatorcontrib>Morse, III, Herbert C</creatorcontrib><creatorcontrib>The United States of America as represented by the Department of Health and Human Services</creatorcontrib><title>Method of inducing memory B cell development and terminal differentiation</title><description>A method is disclosed herein for inducing differentiation of a B cell progenitor into a memory B cells and/or a plasma cell. The method includes contacting a population of cells including a mature B cell or a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. In one embodiment, the B cell progenitor is an immature B cell. A method is also disclosed for enhancing an immune response. The method includes contacting a population of cells including a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. The memory B cells and/or the plasma cell are then introduced into the subject to enhance the immune response. A method is also disclosed for treating a subject with a condition comprising a specific deficiency of at least one of memory B cells and plasma cells. A method is disclosed for identifying an agent with a physiological effect on one or more of a memory B cell and a plasma cell differentiation. A method is also disclosed for identifying agents that inhibit an activity of IL-21. Methods are also disclosed for inducing apoptosis of a B cell and for decreasing the number of B cells. A method is also described for producing a B cell hybridoma.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNikEKAjEMAHvxIOof8gFBXLCeFUUP3rxL2KZroE2WNiv4eyv4AE8DMzN31xvZUwNoBJYw9SwDZMpa3nCAnlKCQC9KOmYSA5QARiWzYAscI5WmGY1Vlm4WMVVa_bhwcD7dj5f1VEe0ttXHUPCLje_8fut33R_LB5zeNb0</recordid><startdate>20080527</startdate><enddate>20080527</enddate><creator>Ettinger, Catherine Rachel</creator><creator>Lipsky, Peter E</creator><creator>Leonard, Warren J</creator><creator>Spolski, Rosanne</creator><creator>Morse, III, Herbert C</creator><scope>EFH</scope></search><sort><creationdate>20080527</creationdate><title>Method of inducing memory B cell development and terminal differentiation</title><author>Ettinger, Catherine Rachel ; Lipsky, Peter E ; Leonard, Warren J ; Spolski, Rosanne ; Morse, III, Herbert C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_073782763</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ettinger, Catherine Rachel</creatorcontrib><creatorcontrib>Lipsky, Peter E</creatorcontrib><creatorcontrib>Leonard, Warren J</creatorcontrib><creatorcontrib>Spolski, Rosanne</creatorcontrib><creatorcontrib>Morse, III, Herbert C</creatorcontrib><creatorcontrib>The United States of America as represented by the Department of Health and Human Services</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ettinger, Catherine Rachel</au><au>Lipsky, Peter E</au><au>Leonard, Warren J</au><au>Spolski, Rosanne</au><au>Morse, III, Herbert C</au><aucorp>The United States of America as represented by the Department of Health and Human Services</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Method of inducing memory B cell development and terminal differentiation</title><date>2008-05-27</date><risdate>2008</risdate><abstract>A method is disclosed herein for inducing differentiation of a B cell progenitor into a memory B cells and/or a plasma cell. The method includes contacting a population of cells including a mature B cell or a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. In one embodiment, the B cell progenitor is an immature B cell. A method is also disclosed for enhancing an immune response. The method includes contacting a population of cells including a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. The memory B cells and/or the plasma cell are then introduced into the subject to enhance the immune response. A method is also disclosed for treating a subject with a condition comprising a specific deficiency of at least one of memory B cells and plasma cells. A method is disclosed for identifying an agent with a physiological effect on one or more of a memory B cell and a plasma cell differentiation. A method is also disclosed for identifying agents that inhibit an activity of IL-21. Methods are also disclosed for inducing apoptosis of a B cell and for decreasing the number of B cells. A method is also described for producing a B cell hybridoma.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_07378276 |
source | USPTO Issued Patents |
title | Method of inducing memory B cell development and terminal differentiation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T02%3A45%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ettinger,%20Catherine%20Rachel&rft.aucorp=The%20United%20States%20of%20America%20as%20represented%20by%20the%20Department%20of%20Health%20and%20Human%20Services&rft.date=2008-05-27&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07378276%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |